Spironolactone Use Not Linked to Increased Risk for Cancer

WEDNESDAY, Feb. 23, 2022 -- Spironolactone use is not associated with an increased risk for cancer, according to a systematic review and meta-analysis published online Feb. 9 in JAMA Dermatology. Kanthi Bommareddy, M.D., from the University of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news